InvestorsHub Logo
Followers 833
Posts 119916
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Monday, 04/11/2016 1:17:22 PM

Monday, April 11, 2016 1:17:22 PM

Post# of 345980
Who cares whether the FDA might approve Baxituximab for marketing, based on some secret plan? Even if FDA did that (which they won’t, of course), the commercial sales would be negligible.

Who in his right mind would prescribe a drug that showed no benefit when added to the control arm in the only phase-3 trial?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News